Walleye Trading’s Insmed INSM Stock Holding History

Walleye Trading’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$622K	Sell	5,834 -1,786	-23%	-$216K	﹤0.01%	2565
2026 Q1	$1.25M	Sell	7,620 -10,037	-57%	-$1.54M	﹤0.01%	2007
2025 Q4	$3.07M	Sell	17,657 -3,428	-16%	-$626K	﹤0.01%	1615
2025 Q3	$3.04M	Buy	+21,085	New	+$2.58M	﹤0.01%	1546
2025 Q1	–	Sell	-1,826	Closed	-$140K	–	4352
2024 Q4	$126K	Buy	1,826 +634	+53%	+$45.7K	﹤0.01%	3455
2024 Q3	$87K	Sell	1,192 -3,706	-76%	-$273K	﹤0.01%	3362
2024 Q2	$328K	Buy	4,898 +432	+10%	+$16.8K	﹤0.01%	2793
2024 Q1	$121K	Sell	4,466 -515	-10%	-$14.4K	﹤0.01%	3683
2023 Q4	$154K	Buy	+4,981	New	+$129K	﹤0.01%	3938
2023 Q2	–	Sell	-9,157	Closed	-$156K	–	4913
2023 Q1	$156K	Buy	9,157 +9,067	+10,074%	+$176K	﹤0.01%	3668
2022 Q4	$1.8K	Sell	90 -33,553	-100%	-$649K	﹤0.01%	4742
2022 Q3	$725K	Buy	+33,643	New	+$807K	﹤0.01%	2548
2020 Q2	–	Sell	-2,383	Closed	-$56.5K	–	4405
2020 Q1	$38K	Buy	+2,383	New	+$56.5K	﹤0.01%	3499
2019 Q2	–	Sell	-2,639	Closed	-$73.5K	–	4250
2019 Q1	$77K	Buy	+2,639	New	+$68.4K	﹤0.01%	3568

Other funds holding INSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Walleye Trading's INSM Position: Q2 2026 in Review

Walleye Trading reduced its Insmed (INSM) stake by 23% in Q2 2026, selling an estimated $216K and leaving 5,834 shares worth $622K. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

Walleye Trading first reported a position in INSM in Q1 2019 and has held it in 14 quarters since. The position peaked at $3.07M in Q4 2025. 281 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Walleye Trading held 5,834 shares of Insmed worth $622K as of Q2 2026.
Walleye Trading sold 1,786 Insmed shares in Q2 2026, an estimated $216K.
Insmed made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2565 holding.
Walleye Trading first reported a position in Insmed in Q1 2019 and has held it in 14 quarters since.
Walleye Trading's Insmed position peaked at $3.07M in Q4 2025.
281 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.